NMRA
Neumora Therapeutics, Inc. · Healthcare
Insider Paul L Berns sold $34K of Neumora Therapeutics, Inc.
Sold$34,459
$3.51Price
9,819Shares
What NMRA did after the filing
- The stock from Thu, Feb 19 close, $3.48
- −42.5%
- S&P 500, same days
- −4.2%
Measured over 30 trading days, to the Apr 2 close.
Traded Tue, Feb 17. Filed Thu, Feb 19, 12:05 PM ET, during the session. Returns use the Feb 19 close and the Apr 2 close. Not investment advice.